IRIS
DE NICOLA, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.671
NA - Nord America 14.098
AS - Asia 9.682
SA - Sud America 1.486
Continente sconosciuto - Info sul continente non disponibili 464
AF - Africa 128
OC - Oceania 8
Totale 46.537
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.854
RU - Federazione Russa 13.410
SG - Singapore 3.418
IE - Irlanda 2.179
CN - Cina 2.116
HK - Hong Kong 1.553
BR - Brasile 1.240
UA - Ucraina 1.171
IT - Italia 1.044
GB - Regno Unito 958
VN - Vietnam 899
DE - Germania 680
IN - India 522
TR - Turchia 333
FI - Finlandia 321
KR - Corea 319
SE - Svezia 299
GR - Grecia 188
JP - Giappone 127
BD - Bangladesh 121
FR - Francia 112
CA - Canada 104
AR - Argentina 96
MX - Messico 63
AT - Austria 58
NL - Olanda 51
BE - Belgio 43
EC - Ecuador 43
IQ - Iraq 36
ES - Italia 35
PK - Pakistan 33
ZA - Sudafrica 33
CZ - Repubblica Ceca 30
CO - Colombia 29
ID - Indonesia 29
MA - Marocco 21
TN - Tunisia 21
JM - Giamaica 20
MY - Malesia 20
VE - Venezuela 20
PH - Filippine 19
CL - Cile 18
IR - Iran 17
PL - Polonia 16
PY - Paraguay 16
UZ - Uzbekistan 16
SA - Arabia Saudita 15
CR - Costa Rica 14
KZ - Kazakistan 12
IL - Israele 11
KE - Kenya 11
LT - Lituania 10
AE - Emirati Arabi Uniti 9
CH - Svizzera 9
NI - Nicaragua 9
UY - Uruguay 9
EG - Egitto 8
EU - Europa 8
PE - Perù 8
PT - Portogallo 8
TH - Thailandia 8
HU - Ungheria 7
SC - Seychelles 7
EE - Estonia 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
AL - Albania 5
AU - Australia 5
BO - Bolivia 5
NP - Nepal 5
OM - Oman 5
RS - Serbia 5
BG - Bulgaria 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GE - Georgia 4
KG - Kirghizistan 4
LB - Libano 4
RO - Romania 4
DK - Danimarca 3
JO - Giordania 3
LV - Lettonia 3
MK - Macedonia 3
PR - Porto Rico 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BZ - Belize 2
CU - Cuba 2
DZ - Algeria 2
GA - Gabon 2
GP - Guadalupe 2
GT - Guatemala 2
GY - Guiana 2
HN - Honduras 2
KH - Cambogia 2
NG - Nigeria 2
Totale 46.041
Salva come PNG Salva come JPEG
Città #
Moscow 4.773
Dublin 2.177
Jacksonville 1.753
Santa Clara 1.635
Hong Kong 1.537
San Jose 1.391
Singapore 1.315
Chandler 1.119
Council Bluffs 847
Ashburn 770
Chicago 497
Bengaluru 441
Princeton 344
Hefei 316
Ho Chi Minh City 309
Seoul 305
Medford 279
Wilmington 270
Beijing 262
Dallas 235
Hanoi 213
Roxbury 210
Boardman 209
Ann Arbor 168
New York 160
San Mateo 157
Falls Church 133
The Dalles 126
Woodbridge 119
Los Angeles 115
Naples 115
São Paulo 114
Istanbul 96
Munich 96
Cambridge 86
Milan 82
Des Moines 81
Bremen 75
Nanjing 69
Jinan 62
Caserta 56
Rome 55
Da Nang 54
Houston 47
Rio de Janeiro 46
Brussels 42
Nuremberg 42
Norwalk 41
Haiphong 38
Atlanta 36
Frankfurt am Main 36
Tokyo 36
Mountain View 35
Shenyang 35
Belo Horizonte 34
Napoli 33
Orem 33
Zhengzhou 33
Saint Petersburg 32
Guangzhou 30
Brooklyn 28
Shanghai 28
Vienna 28
Brno 27
Tianjin 24
Helsinki 23
Curitiba 22
Changsha 21
San Francisco 21
Biên Hòa 20
Phoenix 20
Düsseldorf 19
Ercolano 19
Hangzhou 19
Hải Dương 19
Montreal 19
Ningbo 19
Bologna 18
Chennai 18
Nanchang 18
Taizhou 18
Brasília 17
Campinas 17
London 17
Mexico City 17
Quito 17
Turku 17
Johannesburg 16
Toronto 16
Boston 15
Kingston 15
Philadelphia 15
Seattle 15
Sorocaba 15
Taiyuan 15
Amsterdam 14
Buenos Aires 14
Dhaka 14
Falkenstein 14
Lanzhou 14
Totale 24.597
Salva come PNG Salva come JPEG
Nome #
Ethanol and in-vitro Vascular Reactivity of Rats Mesenteric-Artery 841
Sustained Recovery of Kidney Function in Patients with ESKD under Chronic Dialysis Treatment: Systematic Review and Meta-Analysis 474
Empagliflozin in Patients with Chronic Kidney Disease 245
A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population 241
Ruolo del refilling plasmatico dopo dialisi alternativa: valutazione dei dati bioimpedenzometrici 210
Reassessment of Ambulatory Blood Pressure Improves Renal Risk Stratification in Nondialysis Chronic Kidney Disease: Long-Term Cohort Study 200
Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels 185
Amino acid loss during dialysis treatment 184
L'impiego dell’ Emodiafiltrazione con reinfusione endogena (HFR) nell'infiammazione cronica idiopatica: una possibile alternativa terapeutica? 183
Absence of acute nephrotoxicity with low doses of cyclosporin: experimental study in the rat 180
Alterazioni del bilancio idro-elettrolitico nell’insufficienza renale acuta: implicazioni cliniche 179
Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects 178
Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology 177
[Hyperuricaemia and Chronic Kidney Disease] 175
Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter Prospective Cohort Study 174
[Anti-diabetics and chronic kidney disease] 174
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 173
[Iron deficiency in ND-CKD: from diagnosis to treatment] 172
Antiproteinuric Response to Dual Blockade of RAS in Primary Glomerulonephritis: Meta-Analysis and Meta-Regression 171
Conversion of darbepoetin to low doses of CERA maintains hemoglobin levels in non-dialysis chronic kidney disease patients 170
Assessment of achieved clinic and ambulatory BP recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. 169
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 168
[Clinical experience with ferric carboxymaltose in non-dialysis chronic kidney disease] 167
Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care 166
Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure 166
CHRONIC CYCLOSPORINE A NEPHROTOXICITY - A MORPHOLOGICAL AND FUNCTIONAL-STUDY IN RATS 164
Assesement of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients wih CKD: a multicenter prospective cohort study 164
Daily nutrient intake in hemodialysis. 163
Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis 163
[Peritoneal dialysis catheter infection with abscess of the abdominal wall in a ADPKD patient] 163
Antiproteinuric response to add-on aliskiren in proteinuric patients treated with dual blockade of the renin-angiotensin system: a 12-month prospective uncontrolled study 162
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy 162
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 162
Area Deprivation and Risk of Death and CKD Progression: Long-Term Cohort Study in Patients under Unrestricted Nephrology Care 160
15-year-change of phenotype and prognosis in non-dialysis CKD patients referred to a nephrology clinic 159
Achievement of target blood pressure levels in chronic kidney disease: a salty question ? 159
Burden of resistant hypertension in hypertensive patients with non-dialysis chronic kidney disease 158
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 157
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 156
Alterations of hydro-electrolyte balance in acute renal failure: clinical implications 156
Blood pressure variability, mortality, and cardiovascular outcomes in CKD patients 155
Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease 154
Clinical management of the patient affected with acute renal failure (ARF) secondary to volume depletion 153
[Epidemiology and prognosis of chronic kidney disease in Italy] 153
Abnormalities of bioimpedance measures in overweight and obese hemodialyzed patients 152
Prevalence and Prognostic Role of Resistant Hypertension in Chronic Kidney Disease Patients 151
[Hyperkalemia treatment in chronic kidney disease patients: overview on new cation exchange resins and possible therapeutic approaches] 151
Chronic Hyperkaliemia in Chronic Kidney Disease: An Old Concern with New Answers 150
Management of hypertension in patients with CKD: differences between primary and tertiary care settings 150
Acute cyclosporine A nephrotoxicity 150
[Census of the renal and dialysis units by Italian Society of Nephrology: structure and organization for renal patient assistance in Italy (2014-2015)] 150
Renal Functional Reserve (RFR) And Antihypertensive Treatments (RXP) in Rats with Goldblatt Hypertension (2K1C) 149
A new diuretic: the Atrial Natriuretic Peptide 149
Acute renal and immunological effects of low-dose cyclosporin in humans 148
Disfunzione renale nell’anziano: processo fisiologico o malattia? 147
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 146
Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease 145
Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey 144
Ruolo dell’ossido nitrico nella regolazione dell’emodinamica glomerulare 144
Antiproteinuric effect of paricalcitol in kidney transplant recipients with severe proteinuria: a prospective cohort study 143
Effect of hemodiafiltration with endogenous reinfusion on overt idiopathic chronic inflammation in maintenance hemodialysis patients: A multicenter longitudinal study. 143
Epidemiology of chronic kidney disease in Italy: the CARHES study 143
Management of hypertension in chronic kidney disease: the Italian multicenter study. 142
Sodium removal by peritoneal dialysis: a systematic review and meta-analysis 142
Anemia: A Connection Between Heart Failure and Kidney Failure 142
Renal Disease 141
Epidemiology of CKD Regression in Patients under Nephrology Care 141
Ferric carboxymatose in non-hemodialysis ckd patients: A longitudinal cohort study 141
Acute effects of cyclosporine on glomerular dynamics--micropuncture study in the rat 140
Epidemiology of chronic kidney disease in Italy: current state and contribution of the CARHES study. 140
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics 140
Role of paracalcitol in the management of non-dialysis CKD: state of art and unmeet needs. 139
Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. 139
Prevalence and Prognosis of Mild Anemia in Non-Dialysis CKD: A Prospective Cohort Study in Outpatient Renal Clinics 139
Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis 138
Acute effects of low-dose cyclosporine on renal function in normal subjects 138
Comprehensive audit of antihypertensive treatment in patients with chronic renal insufficiency (CRI): The Italian Multicentre survey 138
Sodium intake and chronic kidney disease 138
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 138
AMBULATORY BLOOD PRESSURE (ABP) AND RESISTANT HYPERTENSION (RH): TWO INCREMENTAL PREDICTORS OF LONG TERM COMPLICATIONS IN NON-DIALYSIS CKD 136
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 136
Sex difference in cardiovascular risk in patients with chronic kidney disease: pooled analysis of four cohort studies 135
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 135
Role of inhibition of atrial natriuretic factor release in the down-regulation of salt excretion 135
Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute rebound 134
Management of hypertension in chronic kidney disease 134
Epidemiologia e Prognosi della Malattia Renale Cronica in Italia 134
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease 134
Volume-Independent Sodium Toxicity in Peritoneal Dialysis: New Insights from Bench to Bed 133
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy 133
Rebound post-dialitico della fosforemia: implicazioni patogenetiche e cliniche 133
Prognosis of CKD Patients Receiving Outpatient Nephrology Care in Italy 133
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy 133
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 132
Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study 132
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. 132
Are all erythropoiesis-stimulating agents created equal? 132
Heart Failure in chronic kidney disease: from epidemiology to therapy. 131
Epidemiology of chronic kidney disease in Italy 131
Waist: hip ratio is a better predictor of cardiovascular risk than BMI in patients with moderate CKD 131
Totale 16.375
Salva come PNG Salva come JPEG
Categoria #
all - tutte 162.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 162.042
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.018 0 0 0 82 726 19 44 56 83 145 213 650
2022/20234.441 422 137 318 363 398 342 10 253 1.992 37 75 94
2023/20241.699 150 49 74 172 613 96 38 30 34 32 125 286
2024/20255.897 16 84 81 184 940 893 821 499 637 998 410 334
2025/202622.817 887 1.204 1.168 1.078 1.769 12.565 1.170 983 881 563 326 223
2026/20273.210 451 712 1.811 236 0 0 0 0 0 0 0 0
Totale 46.537